Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ARL vs NHI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ARL
American Realty Investors, Inc.

Real Estate - Development

Real EstateNYSE • US
Market Cap$220M
5Y Perf.+83.8%
NHI
National Health Investors, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$3.58B
5Y Perf.+38.6%

ARL vs NHI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ARL logoARL
NHI logoNHI
IndustryReal Estate - DevelopmentREIT - Healthcare Facilities
Market Cap$220M$3.58B
Revenue (TTM)$50M$403M
Net Income (TTM)$16M$148M
Gross Margin-25.1%61.3%
Operating Margin-12.9%48.5%
Forward P/E0.7x21.8x
Total Debt$214M$1.16B
Cash & Equiv.$14M$20M

ARL vs NHILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ARL
NHI
StockMay 20May 26Return
American Realty Inv… (ARL)100183.8+83.8%
National Health Inv… (NHI)100138.6+38.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: ARL vs NHI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NHI leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. American Realty Investors, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
ARL
American Realty Investors, Inc.
The Real Estate Income Play

ARL is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 168.4% 10Y total return vs NHI's 60.5%
  • Lower volatility, beta 1.00, Low D/E 26.2%, current ratio 166.96x
  • Beta 1.00, current ratio 166.96x
Best for: long-term compounding and sleep-well-at-night
NHI
National Health Investors, Inc.
The Real Estate Income Play

NHI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta -0.08, yield 4.9%
  • Rev growth 12.9%, EPS growth -3.5%, 3Y rev CAGR 10.8%
  • 12.9% FFO/revenue growth vs ARL's 5.7%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthNHI logoNHI12.9% FFO/revenue growth vs ARL's 5.7%
ValueARL logoARLLower P/E (0.7x vs 21.8x)
Quality / MarginsNHI logoNHI36.8% margin vs ARL's 31.4%
Stability / SafetyARL logoARLLower D/E ratio (26.2% vs 75.6%)
DividendsNHI logoNHI4.9% yield; 1-year raise streak; the other pay no meaningful dividend
Momentum (1Y)ARL logoARL+12.9% vs NHI's +1.5%
Efficiency (ROA)NHI logoNHI5.4% ROA vs ARL's 1.5%, ROIC 5.6% vs -0.5%

ARL vs NHI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ARLAmerican Realty Investors, Inc.
FY 2025
Residential Segment
69.6%$34M
Commercial Segments
30.4%$15M
NHINational Health Investors, Inc.
FY 2025
Real Estate Investment Segment
78.7%$296M
Senior Housing Operating Portfolio
21.3%$80M

ARL vs NHI — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNHILAGGINGARL

Income & Cash Flow (Last 12 Months)

NHI leads this category, winning 5 of 6 comparable metrics.

NHI is the larger business by revenue, generating $403M annually — 8.1x ARL's $50M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to ARL's 31.4%. On growth, NHI holds the edge at +29.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricARL logoARLAmerican Realty I…NHI logoNHINational Health I…
RevenueTrailing 12 months$50M$403M
EBITDAEarnings before interest/tax$6M$282M
Net IncomeAfter-tax profit$16M$148M
Free Cash FlowCash after capex-$6M$226M
Gross MarginGross profit ÷ Revenue-25.1%+61.3%
Operating MarginEBIT ÷ Revenue-12.9%+48.5%
Net MarginNet income ÷ Revenue+31.4%+36.8%
FCF MarginFCF ÷ Revenue-11.1%+56.1%
Rev. Growth (YoY)Latest quarter vs prior year+8.1%+29.7%
EPS Growth (YoY)Latest quarter vs prior year+61.0%+10.8%
NHI leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

ARL leads this category, winning 4 of 5 comparable metrics.

At 14.0x trailing earnings, ARL trades at a 43% valuation discount to NHI's 24.5x P/E. On an enterprise value basis, NHI's 17.0x EV/EBITDA is more attractive than ARL's 68.3x.

MetricARL logoARLAmerican Realty I…NHI logoNHINational Health I…
Market CapShares × price$220M$3.6B
Enterprise ValueMkt cap + debt − cash$420M$4.7B
Trailing P/EPrice ÷ TTM EPS14.03x24.46x
Forward P/EPrice ÷ next-FY EPS est.0.66x21.82x
PEG RatioP/E ÷ EPS growth rate1.21x
EV / EBITDAEnterprise value multiple68.32x16.96x
Price / SalesMarket cap ÷ Revenue4.40x9.46x
Price / BookPrice ÷ Book value/share0.27x2.26x
Price / FCFMarket cap ÷ FCF16.26x
ARL leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

NHI leads this category, winning 5 of 9 comparable metrics.

NHI delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $2 for ARL. ARL carries lower financial leverage with a 0.26x debt-to-equity ratio, signaling a more conservative balance sheet compared to NHI's 0.76x. On the Piotroski fundamental quality scale (0–9), NHI scores 6/9 vs ARL's 3/9, reflecting solid financial health.

MetricARL logoARLAmerican Realty I…NHI logoNHINational Health I…
ROE (TTM)Return on equity+1.9%+9.8%
ROA (TTM)Return on assets+1.5%+5.4%
ROICReturn on invested capital-0.5%+5.6%
ROCEReturn on capital employed-0.6%+8.0%
Piotroski ScoreFundamental quality 0–936
Debt / EquityFinancial leverage0.26x0.76x
Net DebtTotal debt minus cash$200M$1.1B
Cash & Equiv.Liquid assets$14M$20M
Total DebtShort + long-term debt$214M$1.2B
Interest CoverageEBIT ÷ Interest expense4.11x3.45x
NHI leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — ARL and NHI each lead in 3 of 6 comparable metrics.

A $10,000 investment in ARL five years ago would be worth $17,584 today (with dividends reinvested), compared to $12,946 for NHI. Over the past 12 months, ARL leads with a +12.9% total return vs NHI's +1.5%. The 3-year compound annual growth rate (CAGR) favors NHI at 19.6% vs ARL's -10.7% — a key indicator of consistent wealth creation.

MetricARL logoARLAmerican Realty I…NHI logoNHINational Health I…
YTD ReturnYear-to-date-16.2%-2.7%
1-Year ReturnPast 12 months+12.9%+1.5%
3-Year ReturnCumulative with dividends-28.7%+71.1%
5-Year ReturnCumulative with dividends+75.8%+29.5%
10-Year ReturnCumulative with dividends+168.4%+60.5%
CAGR (3Y)Annualised 3-year return-10.7%+19.6%
Evenly matched — ARL and NHI each lead in 3 of 6 comparable metrics.

Risk & Volatility

NHI leads this category, winning 2 of 2 comparable metrics.

NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than ARL's 1.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NHI currently trades 81.2% from its 52-week high vs ARL's 68.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricARL logoARLAmerican Realty I…NHI logoNHINational Health I…
Beta (5Y)Sensitivity to S&P 5001.00x-0.08x
52-Week HighHighest price in past year$20.00$90.94
52-Week LowLowest price in past year$11.66$68.80
% of 52W HighCurrent price vs 52-week peak+68.0%+81.2%
RSI (14)Momentum oscillator 0–10044.123.8
Avg Volume (50D)Average daily shares traded3K330K
NHI leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

NHI leads this category, winning 1 of 1 comparable metric.

NHI is the only dividend payer here at 4.88% yield — a key consideration for income-focused portfolios.

MetricARL logoARLAmerican Realty I…NHI logoNHINational Health I…
Analyst RatingConsensus buy/hold/sellHold
Price TargetConsensus 12-month target$85.40
# AnalystsCovering analysts18
Dividend YieldAnnual dividend ÷ price+4.9%
Dividend StreakConsecutive years of raises01
Dividend / ShareAnnual DPS$3.61
Buyback YieldShare repurchases ÷ mkt cap+0.5%0.0%
NHI leads this category, winning 1 of 1 comparable metric.
Key Takeaway

NHI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARL leads in 1 (Valuation Metrics). 1 tied.

Best OverallNational Health Investors, … (NHI)Leads 4 of 6 categories
Loading custom metrics...

ARL vs NHI: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is ARL or NHI a better buy right now?

For growth investors, National Health Investors, Inc.

(NHI) is the stronger pick with 12. 9% revenue growth year-over-year, versus 5. 7% for American Realty Investors, Inc. (ARL). American Realty Investors, Inc. (ARL) offers the better valuation at 14. 0x trailing P/E (0. 7x forward), making it the more compelling value choice. Analysts rate National Health Investors, Inc. (NHI) a "Hold" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ARL or NHI?

On trailing P/E, American Realty Investors, Inc.

(ARL) is the cheapest at 14. 0x versus National Health Investors, Inc. at 24. 5x. On forward P/E, American Realty Investors, Inc. is actually cheaper at 0. 7x.

03

Which is the better long-term investment — ARL or NHI?

Over the past 5 years, American Realty Investors, Inc.

(ARL) delivered a total return of +75. 8%, compared to +29. 5% for National Health Investors, Inc. (NHI). Over 10 years, the gap is even starker: ARL returned +197. 4% versus NHI's +60. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ARL or NHI?

By beta (market sensitivity over 5 years), National Health Investors, Inc.

(NHI) is the lower-risk stock at -0. 08β versus American Realty Investors, Inc. 's 1. 00β — meaning ARL is approximately -1289% more volatile than NHI relative to the S&P 500. On balance sheet safety, American Realty Investors, Inc. (ARL) carries a lower debt/equity ratio of 26% versus 76% for National Health Investors, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ARL or NHI?

By revenue growth (latest reported year), National Health Investors, Inc.

(NHI) is pulling ahead at 12. 9% versus 5. 7% for American Realty Investors, Inc. (ARL). On earnings-per-share growth, the picture is similar: American Realty Investors, Inc. grew EPS 206. 6% year-over-year, compared to -3. 5% for National Health Investors, Inc.. Over a 3-year CAGR, NHI leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ARL or NHI?

National Health Investors, Inc.

(NHI) is the more profitable company, earning 37. 6% net margin versus 31. 4% for American Realty Investors, Inc. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus -12. 9% for ARL. At the gross margin level — before operating expenses — NHI leads at 36. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ARL or NHI more undervalued right now?

On forward earnings alone, American Realty Investors, Inc.

(ARL) trades at 0. 7x forward P/E versus 21. 8x for National Health Investors, Inc. — 21. 2x cheaper on a one-year earnings basis.

08

Which pays a better dividend — ARL or NHI?

In this comparison, NHI (4.

9% yield) pays a dividend. ARL does not pay a meaningful dividend and should not be held primarily for income.

09

Is ARL or NHI better for a retirement portfolio?

For long-horizon retirement investors, National Health Investors, Inc.

(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 9% yield). Both have compounded well over 10 years (NHI: +60. 5%, ARL: +197. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ARL and NHI?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ARL is a small-cap deep-value stock; NHI is a small-cap income-oriented stock. NHI pays a dividend while ARL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ARL

Quality Mega-Cap Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 18%
Run This Screen
Stocks Like

NHI

High-Growth Quality Leader

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 22%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ARL and NHI on the metrics below

Revenue Growth>
%
(ARL: 8.1% · NHI: 29.7%)
Net Margin>
%
(ARL: 31.4% · NHI: 36.8%)
P/E Ratio<
x
(ARL: 14.0x · NHI: 24.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.